Publicaciones en las que colabora con María Fernanda Borges (20)

2024

  1. Exploring Nanocarriers for Boosting Entacapone Bioavailability: A Journey through System Characterization and Assessment of Toxicity and Pharmacological and 2D Permeability Paybacks

    ACS Applied Materials and Interfaces

  2. Rescuing a Troubled Tolcapone with PEGylated PLGA Nanoparticles: Design, Characterization, and Hepatotoxicity Evaluation

    ACS Applied Materials and Interfaces, Vol. 16, Núm. 17, pp. 21522-21533

2023

  1. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

2022

  1. Coumarin-Resveratrol-Inspired Hybrids as Monoamine Oxidase B Inhibitors: 3-Phenylcoumarin versus trans-6-Styrylcoumarin

    Molecules, Vol. 27, Núm. 3

2021

  1. Design and characterization of Nanostructured lipid carriers (NLC) and Nanostructured lipid carrier-based hydrogels containing Passiflora edulis seeds oil

    International Journal of Pharmaceutics, Vol. 600

2018

  1. PEGylated PLGA Nanoparticles As a Smart Carrier to Increase the Cellular Uptake of a Coumarin-Based Monoamine Oxidase B Inhibitor

    ACS Applied Materials and Interfaces, Vol. 10, Núm. 46, pp. 39557-39569

2017

  1. MAO inhibitory activity of bromo-2-phenylbenzofurans: Synthesis,: in vitro study, and docking calculations

    MedChemComm, Vol. 8, Núm. 9, pp. 1788-1796

  2. Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors

    European Journal of Medicinal Chemistry, Vol. 139, pp. 1-11

2016

  1. Computational Drug Target Screening through Protein Interaction Profiles

    Scientific Reports, Vol. 6

2015

  1. 3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases

    ChemMedChem, Vol. 10, Núm. 12, pp. 2071-2079

  2. Design, synthesis and antibacterial study of new potent and selective coumarin-chalcone derivatives for the treatment of tenacibaculosis

    Bioorganic and Medicinal Chemistry, Vol. 23, Núm. 21, pp. 7045-7052

2014

  1. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases

    Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383

2013

  1. Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors

    European Journal of Medicinal Chemistry, Vol. 59, pp. 75-90

2012

  1. 8-Substituted 3-Arylcoumarins as Potent and Selective MAO-B Inhibitors: Synthesis, Pharmacological Evaluation, and Docking Studies

    ChemMedChem, Vol. 7, Núm. 3, pp. 464-470

  2. Exploring nitrostyrene as a scaffold for a new class a of monoamine oxidase inhibitors

    Letters in Drug Design and Discovery, Vol. 9, Núm. 10, pp. 958-961

2011

  1. Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 2, pp. 707-709

  2. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors

    Journal of Medicinal Chemistry, Vol. 54, Núm. 14, pp. 5165-5173

2010

  1. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 20, Núm. 17, pp. 5157-5160

  2. Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins

    Molecules, Vol. 15, Núm. 1, pp. 270-279

  3. Synthesis of carbocyclic pyrimidine nucleosides using the Mitsunobu reaction: O2- vs. N1-alkylation

    Helvetica Chimica Acta, Vol. 93, Núm. 2, pp. 309-313